Tools & Resources

  • Techical Documents

    • February 2, 2022

      Measurement for improvement is an important part of participation in the TOP Collaborative. Measurement tells us if we are improving and reaching our aims, helps teams communicate about their improvement efforts, and ultimately demonstrate the impact on the community.

    • January 24, 2022

      To facilitate the process of selecting interventions by teams participating in the TOP Collaborative, the TOP
      faculty has developed two resources: a Driver Diagram (a graphic to illustrate factors that contribute to the
      overall TOP aims) and a Change Package (a listing of interventions for consideration by TOP teams to test in
      working towards reaching their individualized aims).

      Attached Files:

    • October 28, 2021

      The TOP Collaborative is a quality improvement (QI) initiative led by the BC Centre for Excellence in HIV/AIDS (BC-CfE) in partnership with Vancouver Coastal Health (VCH) Mental Health Services.

      Attached Files:

    • October 27, 2021

      The Preparation Resource Manual contains activities and tips to help your team prepare for successful participation in the Treatment Optimization of Psychosis Collaborative.

      Attached Files:

  • Reporting Tools

    • October 8, 2021

      The Plan-Do-Study-Act (PDSA) cycle is a useful tool for documenting a test of change. Running a PDSA cycle is another way of saying testing a change- you develop a plan to test the change (Plan), carry out the test (Do), observe, analyze, and learn from the test (Study), and determine what modifications, if any, to make for the next cycle (Act).

      Attached Files:

    • August 30, 2021

      This short guide should answer some initial questions you might have about the TOP Collaborative Reporting Platform.

  • Team Generated Tools and Resources

  • Resources

  • Clinical Resources

    • June 21, 2022

      This document contains clickable external links. For best results, please right click and click on “Save Link As” to download rather than view in browser.

    • May 3, 2022
    • April 5, 2022

      Recommended for healthy individuals ages 18-40 years old with no medical conditions and no history of clozapine-related reactions

    • April 5, 2022

      Preferred recommended titration schedule for community initiation of clozapine

    • April 5, 2022

      For clients that require a slower titration schedule (for example, 6.25mg increments) for various reasons OR for clients doing a clozapine restart (after a short period of discontinuation if there have been no problems or adverse effects) and starting from half of original dose.

    • April 5, 2022

      A resource tool for health clinicians caring for clients optimizing
      psychosis treatment in the Vancouver Community.

    • March 21, 2022

      Clozapine order sets for regular titration schedule for physicians.

    • January 21, 2022

      This is the VCH decision support tool for clozapine monitoring and management in community. This document contains guidelines for vitals and side effects monitoring, administrative protocols for clozapine registration, and monitoring tools. Please refer to VCH SHOP for most up to date version.

    • September 6, 2021

      An educational pamphlet to provide your client that summarizes key information about clozapine, including its actions, side effects, what to do and not to do, when to see a care provider, and useful contacts. (Sourced from: Clozapine Collaborative 2019, and supported by Community Engagement Advisory Network, VCH)

      Attached Files:

    • September 6, 2021
    • September 6, 2021

      Glossary for HoNOS Score Sheet

    • September 6, 2021
    • September 6, 2021

      Data gathered from this assessment procedure are applied to the PANSS ratings. Each of the 30 items is accompanied by a specific definition as well as detailed anchoring criteria for all seven rating points.

    • September 6, 2021

      A pamphlet to organize a client’s appointments during their clozapine titration. It also includes information about clozapine and side effects, including guidance on when and where to seek help during initial clozapine titration.
      (Sourced from: Clozapine Collaborative 2019)

    • September 6, 2021

      This tool helps monitor metabolic syndrome risk factors, including scheduling of monitoring and guidance on interventions.
      (Sourced from: Vancouver Community Mental Health, VCH)

    • September 6, 2021
    • September 6, 2021

      This tools helps guide care and treatment for any client experiencing treatment-resistant schizophrenia or schizoaffective disorders. Based on the Canadian Schizophrenia Guidelines.
      (Sourced from: SME Group, TOP Collaborative 2021, VCH)

    • September 6, 2021

      Information you can provide your client that opens up the conversation for optimizing their psychosis treatment and the benefits of clozapine. (Sourced from: Clozapine Collaborative 2019, VCH)

      Attached Files:

  • Video Resources

The TOP Collaborative is supported by: